Clinical Trial Update: Early Retinal Neurodegeneration As Risk Factor, Biomarker and Pharmacological Target of Diabetic Retinopathy

View source ↗

Summary

Clinical trial update notes a study investigating early retinal neurodegeneration as a risk factor, biomarker, and pharmacological target in diabetic retinopath…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy

Snippet

Sponsor: IRCCS Ospedale San Raffaele | Conditions: Diabetic Retinopathy, Diabetic Retinopathy Associated with Type 2 Diabetes Mellitus | Status: RECRUITING